New York State Common Retirement Fund
ZBIO

New York State Common Retirement Fund’s Zenas BioPharma ZBIO Stock Holding History

New York State Common Retirement Fund’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Buy
10,300
+4,100
+66% +$81.5K ﹤0.01% 2258
2026
Q1 		$121K Hold
6,200
– – ﹤0.01% 2442
2025
Q4 		$225K Hold
6,200
– – ﹤0.01% 2246
2025
Q3 		$138K Hold
6,200
– – ﹤0.01% 2463
2025
Q2 		$60.1K Hold
6,200
– – ﹤0.01% 2888
2025
Q1 		$49K Buy
+6,200
New +$48.5K ﹤0.01% 2783

Other funds holding ZBIO

IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

New York State Common Retirement Fund's ZBIO Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Zenas BioPharma (ZBIO) stake by 66% in Q2 2026, buying an estimated $81.5K and bringing the position to 10,300 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

New York State Common Retirement Fund first reported a position in ZBIO in Q1 2025 and has held it in 6 quarters since. 17 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • New York State Common Retirement Fund held 10,300 shares of Zenas BioPharma worth $261K as of Q2 2026.
  • New York State Common Retirement Fund bought 4,100 Zenas BioPharma shares in Q2 2026, an estimated $81.5K.
  • Zenas BioPharma made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2258 holding.
  • New York State Common Retirement Fund first reported a position in Zenas BioPharma in Q1 2025 and has held it in 6 quarters since.
  • 17 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.